心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2016 冠心病合理用药指南

2016-06-30 《中国医学前沿杂志（电子版）》.2016,8(6):19-107.

冠心病合理用药

《冠心病合理用药指南》共9章内容，由韩雅玲院士、周玉杰教授、霍勇教授三位主编，主要目的是为了指导基层医务工作者合理使用药物的作用，解决一些临床治疗用药的疑难问题，提高医生合理使用药物的能力和水平，有效控制心血管病蔓延，使更多的基层医务工作者和患者受益。

中文标题：

2016 冠心病合理用药指南

发布机构：

发布日期：

2016-06-30

简要介绍：

《冠心病合理用药指南》共9章内容，由韩雅玲院士、周玉杰教授、霍勇教授三位主编，主要目的是为了指导基层医务工作者合理使用药物的作用，解决一些临床治疗用药的疑难问题，提高医生合理使用药物的能力和水平，有效控制心血管病蔓延，使更多的基层医务工作者和患者受益。

制定者：
国家卫生计生委合理用药专家委员会 
中国药师协会

拓展指南：与冠心病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 冠心病合理用药指南)] GetToolGuiderByIdResponse(projectId=1, id=6eac11c001236a19, title=2016 冠心病合理用药指南, enTitle=, guiderFrom=《中国医学前沿杂志（电子版）》.2016,8(6):19-107., authorId=null, author=, summary=《冠心病合理用药指南》共9章内容，由韩雅玲院士、周玉杰教授、霍勇教授三位主编，主要目的是为了指导基层医务工作者合理使用药物的作用，解决一些临床治疗用药的疑难问题，提高医生合理使用药物的能力和水平，有效控制心血管病蔓延，使更多的基层医务工作者和患者受益。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Jun 30 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<div>《冠心病合理用药指南》共9章内容，由韩雅玲院士、周玉杰教授、霍勇教授三位主编，主要目的是为了指导基层医务工作者合理使用药物的作用，解决一些临床治疗用药的疑难问题，提高医生合理使用药物的能力和水平，有效控制心血管病蔓延，使更多的基层医务工作者和患者受益。</div> <div><br> </div> <span style="font-weight: bold;">制定者：</span> <div>国家卫生计生委合理用药专家委员会 </div> <div>中国药师协会</div> <div><br> </div> 拓展指南：<strong>与<font color=red>冠心病</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6eac11c001236a19" title="2016 冠心病合理用药指南" target=_blank>2016 冠心病合理用药指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3d5601c0011936d3" title="2015 AHA/ACC/ASH 冠心病患者高血压治疗的科学声明" target=_blank>2015 AHA/ACC/ASH 冠心病患者高血压治疗的科学声明</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=850321c0011e70e8" title="2015 冠心病患者运动治疗中国专家共识" target=_blank>2015 冠心病患者运动治疗中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8be761c00116a9d6" title="2013ACC AHA 降低成年人动脉粥样硬化冠心病风险血脂治疗指南(英文)" target=_blank>2013ACC AHA 降低成年人动脉粥样硬化冠心病风险血脂治疗指南(英文)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=531d81c001158aa3" title="2016 ACC/AHA指南：冠心病患者双抗治疗持续时间（更新）" target=_blank>2016 ACC/AHA指南：冠心病患者双抗治疗持续时间（更新）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%86%A0%E5%BF%83%E7%97%85" target=_blank>有关冠心病更多指南</a></ul>, tagList=[TagDto(tagId=703, tagName=冠心病), TagDto(tagId=15414, tagName=合理用药)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=null, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15201, appHits=1131, showAppHits=5, pcHits=11258, showPcHits=3511, likes=178, shares=54, comments=6, approvalStatus=1, publishedTime=Fri Jul 15 16:05:10 CST 2016, publishedTimeString=2016-06-30, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Jul 15 16:05:10 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 00:09:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 冠心病合理用药指南)])
2016 冠心病合理用药指南
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=924733, encodeId=fd0a924e3386, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210124/2959859c08784950bc188459d8d7c2c1/3509ed0b3e3e4ca08f78e8a9232d2e4c.jpg, createdBy=24f61480129, createdName=小豁牙, createdTime=Mon Feb 15 12:19:32 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907385, encodeId=018090e3854f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Sat Dec 12 20:11:26 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352797, encodeId=ec93352e97d8, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c412484450, createdName=1246602bm15(暂无昵称), createdTime=Fri Nov 16 22:39:13 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94562, encodeId=30589456295, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrvmbupmXRh2HRNnd7fMeWzl9uDQabJkEdKYQK3pxTUcUxtBsls4rVY3vfD2sjjTtAf3GGp88HMCvWsEtdyKjGKO/0, createdBy=b9a31928171, createdName=tgpp, createdTime=Mon Jul 25 11:08:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2021-02-15 小豁牙

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=924733, encodeId=fd0a924e3386, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210124/2959859c08784950bc188459d8d7c2c1/3509ed0b3e3e4ca08f78e8a9232d2e4c.jpg, createdBy=24f61480129, createdName=小豁牙, createdTime=Mon Feb 15 12:19:32 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907385, encodeId=018090e3854f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Sat Dec 12 20:11:26 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352797, encodeId=ec93352e97d8, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c412484450, createdName=1246602bm15(暂无昵称), createdTime=Fri Nov 16 22:39:13 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94562, encodeId=30589456295, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrvmbupmXRh2HRNnd7fMeWzl9uDQabJkEdKYQK3pxTUcUxtBsls4rVY3vfD2sjjTtAf3GGp88HMCvWsEtdyKjGKO/0, createdBy=b9a31928171, createdName=tgpp, createdTime=Mon Jul 25 11:08:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2020-12-12 147e4706m08暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=924733, encodeId=fd0a924e3386, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210124/2959859c08784950bc188459d8d7c2c1/3509ed0b3e3e4ca08f78e8a9232d2e4c.jpg, createdBy=24f61480129, createdName=小豁牙, createdTime=Mon Feb 15 12:19:32 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907385, encodeId=018090e3854f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Sat Dec 12 20:11:26 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352797, encodeId=ec93352e97d8, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c412484450, createdName=1246602bm15(暂无昵称), createdTime=Fri Nov 16 22:39:13 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94562, encodeId=30589456295, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrvmbupmXRh2HRNnd7fMeWzl9uDQabJkEdKYQK3pxTUcUxtBsls4rVY3vfD2sjjTtAf3GGp88HMCvWsEtdyKjGKO/0, createdBy=b9a31928171, createdName=tgpp, createdTime=Mon Jul 25 11:08:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2018-11-16 1246602bm15(暂无昵称)

    棒

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=924733, encodeId=fd0a924e3386, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210124/2959859c08784950bc188459d8d7c2c1/3509ed0b3e3e4ca08f78e8a9232d2e4c.jpg, createdBy=24f61480129, createdName=小豁牙, createdTime=Mon Feb 15 12:19:32 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907385, encodeId=018090e3854f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Sat Dec 12 20:11:26 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352797, encodeId=ec93352e97d8, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c412484450, createdName=1246602bm15(暂无昵称), createdTime=Fri Nov 16 22:39:13 CST 2018, time=2018-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94562, encodeId=30589456295, content=非常好！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrvmbupmXRh2HRNnd7fMeWzl9uDQabJkEdKYQK3pxTUcUxtBsls4rVY3vfD2sjjTtAf3GGp88HMCvWsEtdyKjGKO/0, createdBy=b9a31928171, createdName=tgpp, createdTime=Mon Jul 25 11:08:00 CST 2016, time=2016-07-25, status=1, ipAttribution=)]
    2016-07-25 tgpp

    非常好！

    0

相关指南

2015 AHA/ACC/ASH 冠心病患者高血压治疗的科学声明

美国心脏病学会(ACC,American College of Cardiology) · 2015-03-30

2015 冠心病患者运动治疗中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2016-04-27

2016 ACC/AHA指南：冠心病患者双抗治疗持续时间（更新）

美国心脏病学会(ACC,American College of Cardiology) · 2016-03-30